Novel possibility of vitreomacular traction treatment

Acta Ophthalmol. 2016 Dec;94(8):e818-e819. doi: 10.1111/aos.13075. Epub 2016 May 11.

Authors

Katarzyna Michalska-Małecka^{1

2}, Katarzyna Witek², Justyna Sierocka-Stępień², Dorota Wyględowska-Promieńska^{1

2}, Mariusz Nowak³

Affiliations

¹ Department of Ophthalmology, School of Medicine in Katowice, Medical University of Silesia, Katowice, Poland.
² University Center of Ophthalmology and Oncology, Independent Public Clinical Hospital, Medical University of Silesia, Katowice, Poland.
³ Pathophysiology Division, Department of Pathophysiology and Endocrinology, School of Medicine with Division of Density, Medical University of Silesia, Zabrze, Poland.

PMID: 27167161
DOI: 10.1111/aos.13075

No abstract available

Publication types

Letter

MeSH terms

Aged
Aged, 80 and over
Eye Diseases / diagnostic imaging
Eye Diseases / drug therapy*
Fibrinolysin / therapeutic use*
Fibrinolytic Agents / therapeutic use*
Humans
Intravitreal Injections
Peptide Fragments / therapeutic use*
Retinal Diseases / diagnostic imaging
Retinal Diseases / drug therapy*
Retrospective Studies
Tissue Adhesions / drug therapy
Tomography, Optical Coherence
Visual Acuity
Vitreous Body / diagnostic imaging
Vitreous Body / drug effects*

Substances

Fibrinolytic Agents
Peptide Fragments
microplasmin
Fibrinolysin